My favourite FTSE 100 share had an awful 2020. I expect much higher returns in 2021!

For most UK investors, 2020 was a year to forget. My favourite FTSE 100 share had a terrible year, but I expect better returns in 2021.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Syringe and vial on blue background

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With only one morning of trading left on the London market in 2020, what a year it’s been for UK investors. This year started innocuously enough, but little did we know that the FTSE 100 would peak in late January. Then, as the Covid-19 virus spread across the globe, share prices worldwide went into complete meltdown.

The FTSE 100 crashes and then rebounds

By 23 March, the FTSE 100 had crashed below 5,000, down almost 2,550 points — more than a third (33.8%) — in under three months. But then the Footsie staged a solid comeback, climbing to hit a post-panic peak above 6,600 earlier this month. On Wednesday, the blue-chip index closed at 6,556 points, up more than three-tenths (31.3%) from its March bottom.

Of course, not all Footsie stocks bounced back after the March meltdown. For many heavyweight and mega-cap shares, it’s been an annus horribilis. Notably, big banks, oil & gas producers and airline shares all had a brutal year. Earlier today, I revealed these 10 shares were the FTSE 100’s biggest dogs in 2020.

This heavyweight was a dog in 2020

Unfortunately, my family’s largest individual FTSE 100 shareholding had a dreadful 2020. Alas, this loss alone equates to several years of income. What’s more, this stressed share was in a sector that had an outstanding 2020 overall: large-cap pharmaceuticals. The smashed share that disappointed me in 2020 is, of course, GlaxoSmithKline (LSE: GSK). For the record, I’ve owned GSK shares pretty much constantly for the past 30 years. Over three decades, I’ve watched this FTSE 100 stalwart grow and evolve into the UK’s #2 pharma business, behind AstraZeneca. But being a GSK owner in 2020 has been a thankless task.

On Wednesday, the GSK share price closed at 1,358p, valuing this pharma giant at £68.5bn. But the shares had peaked at 1,857p on 24 January, almost exactly £5 above the current price. What’s more, GSK’s stock is down almost a quarter (24.5%) over the past 12 months. This places it at #85 in the FTSE 100 in terms of share-price performance in 2020. In other words, GSK is only five places above the 10 dogs I mentioned in my earlier article. Hardly much of an accolade, I admit.

GSK is a dividend dynamo

Although GSK shares have had an awful 2020, I expect much higher returns from this FTSE 100 stock in 2021. Indeed, throughout this year, I’ve continued to invest my quarterly cash dividends into yet more GSK stock at lower prices. In time, I expect this reinvestment to pay off, because GSK shares are looking remarkably cheap right now. They currently trade on a price-to-earnings ratio of 10.7 with an earnings yield of 9.4%. Trust me, for GSK, this is very attractive in historical terms.

One reason I’ve held onto GSK through good years and bad is because it pays one of the biggest dividends in the FTSE 100. At 80p a share, the annual dividend costs GSK around £4bn each year in cash outflow. On the current share price of 1,358p, this equates to a bumper dividend yield of 5.9% — almost twice the 3.1% on offer from the wider FTSE 100.

In summary, my family portfolio has lost a fortune from being invested in GSK in 2020. But I remain confident that I’ll make this loss back (and more) in the years ahead. That’s why I’ll keep buying this FTSE 100 stock at these low prices!

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Cliffdarcy owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »